342 related articles for article (PubMed ID: 21561377)
1. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
Oh KS; Lee S; Lee BH
Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
[TBL] [Abstract][Full Text] [Related]
2. Development of a time-resolved fluorometric assay for the high throughput screening of melanin concentrating hormone receptor antagonists.
Lee S; Kim GD; Park WK; Cho H; Byung Ho Lee ; Yoo SE; Jae Yang Kong
J Pharmacol Toxicol Methods; 2006; 53(3):242-7. PubMed ID: 16249102
[TBL] [Abstract][Full Text] [Related]
3. A high-throughput fluorescent polarization assay for nuclear receptor binding utilizing crude receptor extract.
Lin S; Bock CL; Gardner DB; Webster JC; Favata MF; Trzaskos JM; Oldenburg KR
Anal Biochem; 2002 Jan; 300(1):15-21. PubMed ID: 11743686
[TBL] [Abstract][Full Text] [Related]
4. Cell-based beta2-adrenergic receptor-ligand binding assay using synthesized europium-labeled ligands and time-resolved fluorescence.
Martikkala E; Lehmusto M; Lilja M; Rozwandowicz-Jansen A; Lunden J; Tomohiro T; Hänninen P; Petäjä-Repo U; Härmä H
Anal Biochem; 2009 Sep; 392(2):103-9. PubMed ID: 19464246
[TBL] [Abstract][Full Text] [Related]
5. [Identification of ligands for human LOX-1 through fluorescence polarization-based high throughput screening].
Zhang TT; Huang ZT; Dai Y; Liu AL; Zhu P; Du GH
Yao Xue Xue Bao; 2005 Sep; 40(9):792-5. PubMed ID: 16342678
[TBL] [Abstract][Full Text] [Related]
6. Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey.
Elshourbagy NA; Douglas SA; Shabon U; Harrison S; Duddy G; Sechler JL; Ao Z; Maleeff BE; Naselsky D; Disa J; Aiyar NV
Br J Pharmacol; 2002 May; 136(1):9-22. PubMed ID: 11976263
[TBL] [Abstract][Full Text] [Related]
7. A comparison of assay performance between the calcium mobilization and the dynamic mass redistribution technologies for the human urotensin receptor.
Lee MY; Mun J; Lee JH; Lee S; Lee BH; Oh KS
Assay Drug Dev Technol; 2014 Aug; 12(6):361-8. PubMed ID: 25147908
[TBL] [Abstract][Full Text] [Related]
8. Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375.
Douglas SA; Behm DJ; Aiyar NV; Naselsky D; Disa J; Brooks DP; Ohlstein EH; Gleason JG; Sarau HM; Foley JJ; Buckley PT; Schmidt DB; Wixted WE; Widdowson K; Riley G; Jin J; Gallagher TF; Schmidt SJ; Ridgers L; Christmann LT; Keenan RM; Knight SD; Dhanak D
Br J Pharmacol; 2005 Jul; 145(5):620-35. PubMed ID: 15852036
[TBL] [Abstract][Full Text] [Related]
9. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes.
Castel H; Diallo M; Chatenet D; Leprince J; Desrues L; Schouft MT; Fontaine M; Dubessy C; Lihrmann I; Scalbert E; Malagon M; Vaudry H; Tonon MC; Gandolfo P
J Neurochem; 2006 Oct; 99(2):582-95. PubMed ID: 16942596
[TBL] [Abstract][Full Text] [Related]
11. Urotensin II evokes neurotransmitter release from rat cerebrocortical slices.
Ono T; Kawaguchi Y; Kudo M; Kushikata T; Hashiba E; Yoshida H; Kudo T; Furukawa K; Douglas SA; Guerrini R; Calo' G; Hirota K
Neurosci Lett; 2008 Aug; 440(3):275-9. PubMed ID: 18572318
[TBL] [Abstract][Full Text] [Related]
12. The expression of recombinant human LOX-1 and identifying its mimic ligands by fluorescence polarization-based high throughput screening.
Zhang T; Huang Z; Dai Y; Chen X; Zhu P; Du G
J Biotechnol; 2006 Oct; 125(4):492-502. PubMed ID: 16735073
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of urotensin II and its receptor in skeletal muscle of diabetic mouse.
Wang HX; Zeng XJ; Liu Y; Wang J; Lu LQ; Hao G; Zhang LK; Tang CS
Regul Pept; 2009 Apr; 154(1-3):85-90. PubMed ID: 19323985
[TBL] [Abstract][Full Text] [Related]
14. The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems.
Behm DJ; Stankus G; Doe CP; Willette RN; Sarau HM; Foley JJ; Schmidt DB; Nuthulaganti P; Fornwald JA; Ames RS; Lambert DG; Calo' G; Camarda V; Aiyar NV; Douglas SA
Br J Pharmacol; 2006 May; 148(2):173-90. PubMed ID: 16547525
[TBL] [Abstract][Full Text] [Related]
15. Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro.
Spinazzi R; Albertin G; Nico B; Guidolin D; Di Liddo R; Rossi GP; Ribatti D; Nussdorfer GG
Int J Mol Med; 2006 Dec; 18(6):1107-12. PubMed ID: 17089015
[TBL] [Abstract][Full Text] [Related]
16. A role for urotensin II in restenosis following balloon angioplasty: use of a selective UT receptor blocker.
Rakowski E; Hassan GS; Dhanak D; Ohlstein EH; Douglas SA; Giaid A
J Mol Cell Cardiol; 2005 Nov; 39(5):785-91. PubMed ID: 16171813
[TBL] [Abstract][Full Text] [Related]
17. [Orn5]URP acts as a pure antagonist of urotensinergic receptors in rat cortical astrocytes.
Diallo M; Jarry M; Desrues L; Castel H; Chatenet D; Leprince J; Vaudry H; Tonon MC; Gandolfo P
Peptides; 2008 May; 29(5):813-9. PubMed ID: 18082287
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy.
Langham RG; Kelly DJ; Gow RM; Zhang Y; Dowling JK; Thomson NM; Gilbert RE
Am J Kidney Dis; 2004 Nov; 44(5):826-31. PubMed ID: 15492948
[TBL] [Abstract][Full Text] [Related]
19. High-throughput fluorescence polarization method for identifying ligands of LOX-1.
Zhang TT; Huang ZT; Dai Y; Chen XP; Zhu P; Du GH
Acta Pharmacol Sin; 2006 Apr; 27(4):447-52. PubMed ID: 16539845
[TBL] [Abstract][Full Text] [Related]
20. Development of a high-throughput fluorescence polarization assay for the discovery of phosphopantetheinyl transferase inhibitors.
Duckworth BP; Aldrich CC
Anal Biochem; 2010 Aug; 403(1-2):13-9. PubMed ID: 20382102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
